Malcolm Salter, Director at C4 Therapeutics, Inc. (CCCC), bought 4,138 shares at $19.00 ($25K) on 2020-10-06, disclosed to the SEC on 2020-10-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,823 | $0 | 0.0% |
| 2 | $19.00 | 1,315 | $25K | 100.0% |
| Total | $6.04 avg | 4,138 | $25K | 100% |
| Filing → |
| CCCC | SELL | 2021-10-15 | $34K | — | Filing → |
| CCCC | SELL | 2021-09-21 | $38K | — | Filing → |
| CCCC | SELL | 2021-08-24 | $31K | — | Filing → |